Back to top
more

Chemours (CC)

(Delayed Data from NYSE)

$19.44 USD

19.44
937,477

+0.10 (0.52%)

Updated Aug 30, 2024 04:00 PM ET

After-Market: $19.44 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 10% (225 out of 251)

Industry: Chemical - Diversified

Better trading starts here.

Zacks News

Chemours (CC) is a Great Momentum Stock: Should You Buy?

Does Chemours (CC) have what it takes to be a top stock pick for momentum investors? Let's find out.

Univar's (UNVR) Unit to Distribute Viton Fluoroelastomers

Univar's (UNVR) ChemPoint's technical expertise across multiple industry segments helps reach new markets and applications to support growth of Viton fluoroelastomers.

Why Chemours (CC) is Such a Great Value Stock Pick Right Now

Chemours (CC) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.

Is Chemours (CC) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Chemours (CC) Prices Offering Of $800M Senior Notes Due 2028

Chemours (CC) to employ the net proceeds along with cash on hand to fund the purchase price as well as unpaid and accrued interest of senior notes due 2023.

All You Need to Know About Chemours (CC) Rating Upgrade to Strong Buy

Chemours (CC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Chemours (CC) Tops Earnings and Revenue Estimates in Q3

Lower volumes and prices hurt sales across Chemours' (CC) Fluoroproducts and Chemical Solutions segments in Q3.

Chemours (CC) Q3 Earnings and Revenues Surpass Estimates

Chemours (CC) delivered earnings and revenue surprises of 46.88% and 5.20%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Why Is Chemours (CC) Up 16.5% Since Last Earnings Report?

Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Chemours (CC) Earnings and Revenues Surpass Estimates in Q2

Chemours' (CC) revenues hurt by lower volumes across all segments in the second quarter.

Chemours (CC) Q2 Earnings and Revenues Beat Estimates

Chemours (CC) delivered earnings and revenue surprises of 100.00% and 1.44%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Why Chemours (CC) Could Beat Earnings Estimates Again

Chemours (CC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Analysts Estimate Chemours (CC) to Report a Decline in Earnings: What to Look Out for

Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Chemours Gets EPA Nod for Glyclean Cleaner for Coronavirus

Chemours (CC) is working closely with customers to ensure that it offers products required for slowing and limiting the spread of the coronavirus.

Why Is Chemours (CC) Up 20.1% Since Last Earnings Report?

Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Chemours (CC) Earnings Beat, Revenues Miss Estimates in Q1

Decline volumes in the Fluoroproducts unit and lower global average prices across all segments hurt Chemours' (CC) Q1 sales.

Chemours (CC) Tops Q1 Earnings Estimates

Chemours (CC) delivered earnings and revenue surprises of 39.22% and -2.77%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Chemours (CC) Q1 Earnings Expected to Decline

Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Chemours Provides Update in Response to Coronavirus Outbreak

Chemours (CC) is likely to use the $300-million proceeds from borrowings in the future for working capital needs or other general corporate purposes.

Are Options Traders Betting on a Big Move in Chemours (CC) Stock?

Investors need to pay close attention to Chemours (CC) stock based on the movements in the options market lately.

Here's Why You Should Hold Onto Chemours (CC) Stock Now

Chemours (CC) should gain from its actions to drive Opteon adoption and boost productivity across its business segments in 2020.

Chemours (CC) Down 34.3% Since Last Earnings Report: Can It Rebound?

Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Chemours (CC) Inaugurates State-of-the-art Innovation Center

Chemours' (CC) new facility is one of Delaware's biggest R&D centers and one of the largest R&D facilities in the chemical industry.

Chemours (CC) Earnings Beat, Revenues Miss Estimates in Q4

Lower volumes and prices in Titanium Technologies and Fluoroproducts units hurt Chemours' (CC) Q4 sales.

Implied Volatility Surging for Chemours (CC) Stock Options

Investors need to pay close attention to Chemours (CC) stock based on the movements in the options market lately.